Endoscopic Surgery for Deep Parathyroid Lesions: A Comprehensive Review

Abstract

Endoscopic surgery has emerged as a minimally invasive alternative to traditional open approaches for the management of deep parathyroid lesions. This review critically appraises the current evidence, technical nuances, and clinical outcomes associated with endoscopic parathyroidectomy for challenging deep-seated parathyroid pathology. The article synthesizes recent advances and guideline recommendations, providing a comprehensive resource for clinicians involved in the surgical management of primary and secondary hyperparathyroidism with deep parathyroid involvement.

Introduction

Deep parathyroid lesions, including ectopic and retrotracheal parathyroid glands, pose significant diagnostic and therapeutic challenges. Traditional open cervical exploration, while effective, is associated with higher morbidity, longer recovery, and greater cosmetic concerns. The evolution of endoscopic surgery, leveraging advanced imaging and minimally invasive techniques, has revolutionized the management landscape for deep parathyroid pathology. This review provides an in-depth analysis of endoscopic parathyroidectomy, focusing on indications, technical considerations, clinical efficacy, and safety.

Epidemiology / Disease Burden

Primary hyperparathyroidism is the third most common endocrine disorder, with an estimated prevalence of 0.1% to 0.4% in the general population. While the majority of parathyroid lesions are superficial and amenable to standard cervical approaches, up to 15% are classified as deep or ectopic. These include mediastinal, retroesophageal, and intrathymic glands, which contribute disproportionately to surgical failures and persistent hyperparathyroidism. Secondary hyperparathyroidism, particularly in chronic kidney disease patients, also increases the likelihood of deep gland involvement, further complicating management.

Pathophysiology

Parathyroid glands originate from the third and fourth pharyngeal pouches, with variable migration during embryogenesis. Aberrant migration results in ectopic localization, with deep parathyroid glands frequently found in the mediastinum, behind the esophagus, or within the thymus. These deep glands are often hyperfunctioning adenomas or hyperplastic in the context of chronic kidney disease. Their atypical location and proximity to vital structures increase surgical complexity and risk.

Risk Factors

Risk factors for deep parathyroid lesions include a history of failed parathyroid surgery, chronic renal insufficiency (predisposing to glandular hyperplasia), prior neck irradiation, and genetic syndromes such as MEN1 and MEN2. Anatomical variations in gland migration and prior surgical manipulation may also contribute to ectopic or deep localization. Understanding these risk factors is vital for preoperative planning and patient counseling.

Clinical Features

Patients with deep parathyroid lesions typically present with features of hyperparathyroidism, including hypercalcemia, nephrolithiasis, osteoporosis, neuropsychiatric symptoms, and gastrointestinal disturbances. Clinical suspicion for deep lesions should be heightened in patients with persistent or recurrent hyperparathyroidism despite prior surgery, or when standard imaging fails to localize the abnormal gland. Ectopic deep lesions may also present as mediastinal masses or with compressive symptoms in rare cases.

Diagnosis

Accurate localization of deep parathyroid glands is essential for successful surgical intervention. High-resolution ultrasonography, sestamibi scintigraphy, 4D computed tomography (CT), and magnetic resonance imaging (MRI) are commonly employed, often in combination. 4D-CT has proven particularly sensitive for identifying deep and ectopic lesions due to its ability to delineate glandular vascularity and anatomical relationships. Intraoperative parathyroid hormone (IOPTH) monitoring further assists in confirming successful gland excision, especially in complex cases.

Treatment & Management

Surgical excision remains the definitive treatment for symptomatic or biochemically significant hyperparathyroidism due to deep parathyroid lesions. Endoscopic parathyroidectomy, through approaches such as the transoral vestibular, video-assisted, or minimally invasive thoracoscopic routes, offers a less invasive alternative to open cervicotomy or sternotomy. These approaches minimize tissue disruption, reduce postoperative pain, and improve cosmetic outcomes. Patient selection, precise preoperative localization, and multidisciplinary collaboration are critical for optimal results. Conversion to open surgery may be necessary in cases with difficult anatomy or intraoperative complications.

Recent Advances / Emerging Therapies

Technological advancements have expanded the armamentarium for minimally invasive surgery. High-definition endoscopes, intraoperative nerve monitoring, and fluorescence-guided imaging have enhanced safety and efficacy. Robotic-assisted parathyroidectomy is emerging as an option for select deep lesions, offering superior dexterity and visualization. Ablative therapies, including radiofrequency ablation and focused ultrasound, are being explored for non-surgical candidates, although long-term data are limited. Ongoing research focuses on refining localization techniques and expanding the indications for minimally invasive and non-surgical modalities.

Guideline Recommendations

Current guidelines from major endocrine and surgical societies endorse minimally invasive parathyroidectomy for cases with accurate preoperative localization and no suspicion of multiglandular disease. For deep or ectopic lesions, a tailored approach often incorporating advanced imaging and intraoperative adjuncts is recommended. Endoscopic and video-assisted techniques are increasingly recognized as safe and effective, provided that surgeons possess adequate experience and institutional resources. Multidisciplinary case review is advocated for complex or recurrent disease.

Conclusion

Endoscopic surgery represents a significant advancement in the management of deep parathyroid lesions, offering high success rates with reduced morbidity and improved patient satisfaction. Careful patient selection, meticulous preoperative planning, and adoption of emerging technologies are key to optimizing outcomes. As the field evolves, ongoing research and guideline updates will further delineate the role of endoscopic and minimally invasive approaches in complex parathyroid surgery.